The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans
Open accessAbstract
Immunotherapeutic ablation of lymphoma is a conceptually attractive treatment strategy that is the subject of intense translational research. Cytotoxic T lymphocytes (CTLs) that are genetically modified to express CD19- or CD20-specific, single-chain antibody-derived chimeric antigen receptors (CARs) display HLA-independent antigen-specific recognition/killing of lymphoma targets. Here, we describe our initial experience in applying CAR-redirected autologous CTL adoptive therapy to patients with recurrent lymphoma. Using plasmid vector electrotransfer/drug selection systems, cloned and polyclonal CAR(+) CTLs were generated from autologous peripheral blood mononuclear cells and expanded in vitro to cell numbers sufficient for clinical use. In 2 FDA-authorized trials, patients with recurrent diffuse large cell lymphoma were treated with cloned CD8(+) CTLs expressing a CD20-specific CAR (along with NeoR) after autologous hematopoietic stem cell transplantation, and patients with refractory follicular lymphoma were treated with polyclonal T cell preparations expressing a CD19-specific CAR (along with HyTK, a fusion of hygromycin resistance and HSV-1 thymidine kinase suicide genes) and low-dose s.c. recombinant human interleukin-2. A total of 15 infusions were administered (5 at 10(8)cells/m(2), 7 at 10(9)cells/m(2), and 3 at 2 x 10(9)cells/m(2)) to 4 patients. Overt toxicities attributable to CTL administration were not observed; however, detection of transferred CTLs in the circulation, as measured by quantitative polymerase chain reaction, was short (24 hours to 7 days), and cellular antitransgene immune rejection responses were noted in 2 patients. These studies reveal the primary barrier to therapeutic efficacy is limited persistence, and provide the rationale to prospectively define T cell populations intrinsically programmed for survival after adoptive transfer and to modulate the immune status of recipients to prevent/delay antitransgene rejection responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lineage relationship and protective immunity of memory CD8 T cell subsets
Wherry, E. J., Teichgräber, V., Becker, T. C., Masopust, D., Kaech, S. M., Antia, R., von Andrian, U. H., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni889 · Cited by 1,864
Betts, M. R., Brenchley, J. M., Price, D. A., De Rosa, S. C., Douek, D. C., Roederer, M., & Koup, R. A. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00265-5 · Cited by 1,587
Pule, M. A., Savoldo, B., Myers, G. D., Rossig, C., Russell, H. V., Dotti, G., Huls, M. H., Liu, E., Gee, A. P., Mei, Z., et al. (2008) · Nature Medicine · doi:10.1038/nm.1882 · Cited by 1,195
Adoptive immunotherapy for cancer: building on success
Gattinoni, L., Powell, D. J., Rosenberg, S. A., & Restifo, N. P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1842 · Cited by 845
Berger, C., Jensen, M. C., Lansdorp, P. M., Gough, M., Elliott, C., & Riddell, S. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32103 · Cited by 824
Self-citationPark, J. R., DiGiusto, D. L., Slovak, M., Wright, C., Naranjo, A., Wagner, J., Meechoovet, H. B., Bautista, C., Chang, W.-C., Ostberg, J. R., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300104 · Cited by 603
Self-citationThe promise and potential pitfalls of chimeric antigen receptors
Sadelain, M., Brentjens, R., & Rivière, I. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.02.009 · Cited by 467
The non-Hodgkin lymphomas: A review of the epidemiologic literature
Alexander, D. D., Mink, P. J., Adami, H.-O., Chang, E. T., Cole, P., Mandel, J. S., & Trichopoulos, D. (2007) · International Journal of Cancer · doi:10.1002/ijc.22719 · Cited by 343
Berger, C., Flowers, M. E., Warren, E. H., & Riddell, S. R. (2006) · Blood · doi:10.1182/blood-2005-08-3503 · Cited by 334
Arrested differentiation, the self-renewing memory lymphocyte, and vaccination
Fearon, D. T., Manders, P., & Wagner, S. D. (2001) · Science · doi:10.1126/science.1062589 · Cited by 265
Cooper, L. J. N., Topp, M. S., Serrano, L. M., Gonzalez, S., Chang, W.-C., Naranjo, A., Wright, C., Popplewell, L., Raubitschek, A., Forman, S. J., et al. (2003) · Blood · doi:10.1182/blood-2002-07-1989 · Cited by 248
Self-citationRedirecting Specificity of T-Cell Populations For CD19 Using the Sleeping Beauty System
Singh, H., Manuri, P. R., Olivares, S., Dara, N., Dawson, M. J., Huls, H., Hackett, P. B., Kohn, D. B., Shpall, E. J., Champlin, R. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5600 · Cited by 246
Self-citationA Decade of Rituximab: Improving Survival Outcomes in Non-Hodgkin's Lymphoma
Molina, A. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.060906.220345 · Cited by 194
Jensen, M. C., Tan, G., Forman, S. J., Wu, A. M., & Raubitschek, A. A. (1998) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.1998.v4.pm9763110 · Cited by 100
Self-citationFu, K., & Hu, Q. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-5698-9_21 · Cited by 89
Arora, N., Hamilton, A. S., Potosky, A. L., Rowland, J. H., Aziz, N. M., Bellizzi, K. M., Klabunde, C. N., McLaughlin, W., & Stevens, J. L. (2007) · Journal of Cancer Survivorship · doi:10.1007/s11764-007-0004-3 · Cited by 66
Akatsuka, Y., Martin, E., Madonik, A. M., Barsoukov, A., & Hansen, J. A. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.530202.x · Cited by 56
Bertoni, F., Zucca, E., & Cavalli, F. (2004) · Current Opinion in Hematology · doi:10.1097/01.moh.0000138682.13354.da · Cited by 31
Timmerman, J. M. (2003) · International Journal of Hematology · doi:10.1007/bf02986612 · Cited by 29
Treatment of mantle cell lymphoma: Current approach and future directions
Brody, J., & Advani, R. H. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.10.001 · Cited by 23
Gisselbrecht, C., Bethge, W. A., Duarte, R. F., Gianni, A. M., Glaß, B., Haïoun, C., Martinelli, G., Nagler, A., Pettengell, R., Sureda, A. M., et al. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705868 · Cited by 18
Engineering Antitumor Immunity by T-Cell Adoptive Immunotherapy
Riddell, S. R. (2007) · Hematology · doi:10.1182/asheducation-2007.1.250 · Cited by 13
Current results and future applications of radioimmunotherapy management of non-Hodgkin's lymphoma
Santos, E. S., Kharfan‐Dabaja, M. A., Ayala, E., & Raez, L. E. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190600923140 · Cited by 11
Immunomodulation in the treatment of haematological malignancies
Cesco-Gaspere, M., Morris, E. C., & Stauss, H. J. (2009) · Clinical and Experimental Medicine · doi:10.1007/s10238-009-0037-1 · Cited by 9
Cited by
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Waldman, A. D., Fritz, J. M., & Lenardo, M. J. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0306-5 · Cited by 4,154
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Grupp, S. A., Kalos, M., Barrett, D., Aplenc, R., Porter, D. L., Rheingold, S. R., Teachey, D. T., Chew, A., Hauck, B., Wright, J. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215134 · Cited by 3,509
Self-citationBrentjens, R. J., Davila, M. L., Riviere, I., Park, J., Wang, X., Cowell, L. G., Bartido, S., Stefanski, J., Taylor, C., Olszewska, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005930 · Cited by 2,063
The Basic Principles of Chimeric Antigen Receptor Design
Sadelain, M., Brentjens, R., & Rivière, I. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0548 · Cited by 1,535
Kochenderfer, J. N., Dudley, M. E., Feldman, S. A., Wilson, W. H., Spaner, D. E., Maric, I., Stetler-Stevenson, M., Phan, G. Q., Hughes, M. S., Sherry, R. M., et al. (2012) · Blood · doi:10.1182/blood-2011-10-384388 · Cited by 1,440
Metadata
- Authors
- Jensen, M. C., Popplewell, L., Cooper, L. J., DiGiusto, D., Kalos, M., Ostberg, J. R., & Forman, S. J.
- Venue
- Biology of Blood and Marrow Transplantation
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 16
- Issue
- 9
- Pages
- 1245-1256
- ISSN
- 1083-8791 (ISSN-L)
- OpenAlex
- W2087857484
- Cited by
- 529
- References
- 24
- FWCI
- 11.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.